In February, Intersect ENT Inc. debuted a new kit in the United States that combines the company’s new Straight Delivery System (SDS) with its Propel Mini Sinus Implant. The launch evolved from what ...
Acquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT ®, Inc. (Nasdaq:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of ...
MENLO PARK, Calif. and BERLIN--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced it has ...
Medtronic closed on its $1.1 billion acquisition of Intersect ENT. The closing comes a few days after the Federal Trade Commission ordered the Dublin-based company to divest Intersect's Fiagon ...
Staying true to its pledge to crack down on potentially anticompetitive megamergers in the healthcare industry, the U.S. Federal Trade Commission has ordered Medtronic and Intersect ENT to adjust the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback